Literature DB >> 22508732

Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial.

Steven P Cohen1, Ronald L White, Connie Kurihara, Thomas M Larkin, Audrey Chang, Scott R Griffith, Christopher Gilligan, Ralph Larkin, Benny Morlando, Paul F Pasquina, Tony L Yaksh, Conner Nguyen.   

Abstract

BACKGROUND: Perineural inhibitors of tumor necrosis factor have recently generated intense interest as an alternative to epidural steroid injections for lumbosacral radiculopathy.
OBJECTIVE: To evaluate whether epidural steroids, etanercept, or saline better improves pain and function in adults with lumbosacral radiculopathy.
DESIGN: A multicenter, 3-group, randomized, placebo-controlled trial conducted from 2008 to 2011. Randomization was computer-generated and stratified by site. Pharmacists prepared the syringes. Patients, treating physicians, and nurses assessing outcomes were blinded to treatment assignment. (ClinicalTrials.gov registration number: NCT00733096)
SETTING: Military and civilian treatment centers. PATIENTS: 84 adults with lumbosacral radiculopathy of less than 6 months' duration. INTERVENTION: 2 epidural injections of steroids, etanercept, or saline, mixed with bupivacaine and separated by 2 weeks. MEASUREMENTS: The primary outcome measure was leg pain 1 month after the second injection. All patients had 1-month follow-up visits; patients whose condition improved remained blinded for the 6-month study period.
RESULTS: The group that received epidural steroids had greater reductions in the primary outcome measure than those who received saline (mean difference, -1.26 [95% CI, -2.79 to 0.27]; P = 0.11) or etanercept (mean difference, -1.01 [CI, -2.60 to 0.58]; P = 0.21). For back pain, smaller differences favoring steroids compared with saline (mean difference, -0.52 [CI, -1.85 to 0.81]; P = 0.44) and etanercept (mean difference, -0.92 [CI,-2.28 to 0.44]; P = 0.18) were observed. The largest differences were noted for functional capacity, in which etanercept fared worse than the other treatments: steroids vs. etanercept (mean difference, -16.16 [CI, -26.05 to -6.27]; P = 0.002), steroids vs. saline (mean difference, -5.87 [CI, -15.59 to 3.85]; P = 0.23), and etanercept vs. saline (mean difference, 10.29 [CI, 0.55 to 20.04]; P = 0.04). More patients treated with epidural steroids (75%) reported 50% or greater leg pain relief and a positive global perceived effect at 1 month than those who received saline (50%) or etanercept (42%) (P = 0.09). LIMITATION: Short-term follow-up, small sample size, and a possibly subtherapeutic dose of etanercept.
CONCLUSION: Epidural steroid injections may provide modest short-term pain relief for some adults with lumbosacral radiculopathy, but larger studies with longer follow-up are needed to confirm their benefits. PRIMARY FUNDING SOURCE: The John P. Murtha Neuroscience and Pain Institute, International Spinal Intervention Society, and Center for Rehabilitation Sciences Research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508732     DOI: 10.7326/0003-4819-156-8-201204170-00397

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   51.598


  34 in total

1.  [Study on epidural steroid injection].

Authors:  K Niemier; M Schindler; T Volk; K Baum; B Wolf; J Eberitsch; W Seidel
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 2.  Role of cytokines in intervertebral disc degeneration: pain and disc content.

Authors:  Makarand V Risbud; Irving M Shapiro
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

Review 3.  [Biotechnological therapies for the treatment of back pain: alternatives to corticosteroids].

Authors:  C Moser; H-J Thiel; D Grönemeyer
Journal:  Orthopade       Date:  2013-12       Impact factor: 1.087

Review 4.  Epidural steroid compared to placebo injection in sciatica: a systematic review and meta-analysis.

Authors:  E J A Verheijen; C A Bonke; E M J Amorij; C L A Vleggeert-Lankamp
Journal:  Eur Spine J       Date:  2021-05-11       Impact factor: 3.134

5.  National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy.

Authors:  Mette Jensen Stochkendahl; Per Kjaer; Jan Hartvigsen; Alice Kongsted; Jens Aaboe; Margrethe Andersen; Mikkel Ø Andersen; Gilles Fournier; Betina Højgaard; Martin Bach Jensen; Lone Donbæk Jensen; Ture Karbo; Lilli Kirkeskov; Martin Melbye; Lone Morsel-Carlsen; Jan Nordsteen; Thorvaldur Skuli Palsson; Zoreh Rasti; Peter Frost Silbye; Morten Zebitz Steiness; Simon Tarp; Morten Vaagholt
Journal:  Eur Spine J       Date:  2017-04-20       Impact factor: 3.134

Review 6.  Mechanical low back pain--a rheumatologist's view.

Authors:  David Borenstein
Journal:  Nat Rev Rheumatol       Date:  2013-09-10       Impact factor: 20.543

Review 7.  Do Epidural Injections Provide Short- and Long-term Relief for Lumbar Disc Herniation? A Systematic Review.

Authors:  Laxmaiah Manchikanti; Ramsin M Benyamin; Frank J E Falco; Alan D Kaye; Joshua A Hirsch
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

8.  Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration.

Authors:  Niloofar Farhang; Matt Ginley-Hidinger; Kristofer C Berrett; Jason Gertz; Brandon Lawrence; Robby D Bowles
Journal:  Hum Gene Ther       Date:  2019-07-17       Impact factor: 5.695

Review 9.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

10.  Fibrin-genipin annulus fibrosus sealant as a delivery system for anti-TNFα drug.

Authors:  Morakot Likhitpanichkul; Yesul Kim; Olivia M Torre; Eugene See; Zepur Kazezian; Abhay Pandit; Andrew C Hecht; James C Iatridis
Journal:  Spine J       Date:  2015-04-23       Impact factor: 4.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.